Clinical Trial Update: Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2

View source ↗

Summary

REACT-AF2 is a completed real-world evidence study evaluating anticoagulation treatment in non-valvular atrial fibrillation across Germany, the United Kingdom, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• Anticoagulant therapy (anticoagulant)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-valvular Atrial Fibrillation | Status: COMPLETED